S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation|
|Celldex Therapeutics Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)|
|Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab|
|Celldex Reports Third Quarter 2014 Results|
|Celldex Announces Publication of Glembatumumab Vedotin Phase 1/2 Studies in the Journal of Clinical Oncology|
|Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014|
|Interim Update from Randomized Phase 2 ReACT Study of Rindopepimut in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Survival Benefit|
|Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference|
|Columbia Laboratories Announces Appointment of New Chief Financial Officer|
|Columbia Laboratories Reports Third Quarter 2014 Financial Results|
Click above to view more mutual fund data and stats for cldx - Celldex Therapeutics Inc.